Skip to main content

Bellevue Group AG

Position in PCVX — Vaxcyte, Inc.

CIK 1674546 Zurich, V8

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$114,628,581
+$45,437,179 QoQ
Shares Held
1,971,935
+65.6% QoQ
Ownership
1.33%
of shares outstanding
% of Portfolio
2.48%
of 13F equity value
Holder Rank
#17
of 329 holders
Holding Since
Jun 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. PCVX ranks #9 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCVX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $114,628,581 1,971,935
2026-03-31 $69,191,402 1,190,697
2025-03-31 $426,310 11,290
2024-12-31 $985,430 12,038
2024-09-30 $1,369,068 11,981
2024-06-30 $1,072,997 14,210
2024-03-31 $904,697 13,244
2023-12-31 $992,240 15,800
2023-09-30 $1,554,890 30,500
2023-06-30 $1,298,440 26,000